Aktualności
The EFIC COVID-19 Task Force was created after realizing the need for news related to COVID-19 being distributed and shared with our community which is looking for advice with regards to pain treatment of their patients. The intended outcome is to distribute relevant news on our website and other communication channels. Our goal here is to put forward what is being said in an objective manner and provide a neutral overview on current research. The information will of course be updated as more research becomes available.
Click here to view the most recent research on COVID-19 and pain. Recent Research on...
i neuralgii półpaścowej
Informuję, że staraniem Zarządu Polskiego Towarzystwa Badania Bólu szczepionka Shingrix stosowana w profilaktyce półpaśca i neuralgii półpaścowej u pacjentów w wieku 65 lat i starszych o zwiększonym ryzyku zachorowania na półpasiec została umieszczona w Obwieszczeniu Ministra Zdrowia z dnia 11 grudnia 2023 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych na 1 stycznia 2024 r. w poz. 3543 z refundacją 50%.
Register for NeuPSIG 2023, the leading international meeting for the latest research and developments in understanding the mechanisms, assessment, prevention, and treatment of neuropathic pain.
Register for NuePSIG 2023 by the early bird deadline of 5 May and be entered to win one of two free full registrations. NeuPSIG 2023 is the premier meeting for the latest research and developments in understanding the mechanisms, assessment, prevention, and treatment of neuropathic pain.